ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,697Medicare Part D Prescriptions Filled, Including Refills

Rank: 334 out of 1128

$458K Total Retail Price of All Prescriptions

Rank: 502 out of 1128

528 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Tennessee
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 528 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 595 537 142 1 2
LISINOPRIL 511 454 109 2 4
FUROSEMIDE 359 312 88 3 7
LEVOTHYROXINE SODIUM 352 317 81 4 1
OMEPRAZOLE 310 245 72 5 5
AMLODIPINE BESYLATE 300 264 61 6 3
LOSARTAN POTASSIUM 239 234* 56 7 16
METFORMIN HCL 236 216 49 8 9
ATORVASTATIN CALCIUM 231 202 61 9 8
GABAPENTIN 224 185 45 10 11
HYDROCODONE-ACETAMINOPHEN 211 182 73 S3 11 6
ALPRAZOLAM 192 175 55 B 12 12
METOPROLOL SUCCINATE 184 171 51 13 26
MELOXICAM 164 159* 43 14 23
ISOSORBIDE MONONITRATE ER 152 152 33 15 65
CARVEDILOL 148 130 31 16 21
METOPROLOL TARTRATE 146 141* 38 17 10
WARFARIN SODIUM 141 141 31 18 17
CLOPIDOGREL 139 139 29 19 18
DONEPEZIL HCL 135 135 37 20 35
ATENOLOL 134 120 34 21 19
ACETAMINOPHEN-CODEINE 128 103 48 S3 22 167
NAMENDA 127 127 28 23 44
LORAZEPAM 127 122* 34 B 23 27
GLIMEPIRIDE 125 113 26 25 32
TRAMADOL HCL 123 86 42 26 29
SERTRALINE HCL 119 105 27 27 22
RANITIDINE HCL 118 113* 27 28 37
CITALOPRAM HBR 109 104* 29 29 20
POLYETHYLENE GLYCOL 3350 101 88 39 30 81
PRAVASTATIN SODIUM 100 95* 19 31 13
PAROXETINE HCL 97 80 21 32 61
TRIAMTERENE-HCTZ 96 91* 29 33 41
POTASSIUM CHLORIDE 93 72 16 34 15
CLONIDINE HCL 90 77 26 35 42
SPIRONOLACTONE 87 82* 15 36 58
DOXAZOSIN MESYLATE 84 79* 22 37 104
LANTUS SOLOSTAR 82 70 12 38 98
HYDRALAZINE HCL 74 74 11 39 62
PANTOPRAZOLE SODIUM 71 54 15 40 25
CHLORTHALIDONE 71 58 20 40 126
DILTIAZEM ER 66 61* 16 42 115
TAMSULOSIN HCL 64 59* 15 43 30
LANTUS 64 52 11 43 64
TRAZODONE HCL 64 59* 20 43 39
ALLOPURINOL 60 55* 20 46 31
NEXIUM 59 54* 12 47 28
FLUTICASONE PROPIONATE 56 51* 24 48 33
BENAZEPRIL HCL 55 <11 <11 49 46
NAPROXEN 53 35 11 50 124
JANUVIA 53 53 12 50 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 52 15 52 38
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.